LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.30 | 21.74 | 86 | 6244 | 0.0138 | 0.1834 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.30 | 21.74 | 10343 | 6244 | 1.6563 | 1.1275 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.27 | 21.74 | 1801 | 6201 | 0.2904 | 0.7187 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.27 | 21.74 | 8335 | 6201 | 1.3439 | 1.0738 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.27 | 21.74 | 70 | 6201 | 0.0113 | 0.1542 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.27 | 21.74 | 10736 | 6201 | 1.7311 | 1.1392 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.24 | 21.74 | 1446 | 6162 | 0.2347 | 0.6740 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.24 | 21.74 | 8635 | 6162 | 1.4013 | 1.0846 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.24 | 21.74 | 24 | 6162 | 0.0039 | 0.0122 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.24 | 21.74 | 11200 | 6162 | 1.8176 | 1.1522 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.21 | 21.74 | 1242 | 6235 | 0.1992 | 0.6413 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.21 | 21.74 | 8890 | 6235 | 1.4257 | 1.0888 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.21 | 21.74 | 19 | 6235 | 0.0030 | -0.0164 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.21 | 21.74 | 11632 | 6235 | 1.8654 | 1.1587 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.18 | 21.74 | 1081 | 6114 | 0.1768 | 0.6163 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.18 | 21.74 | 9161 | 6114 | 1.4983 | 1.1019 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.18 | 21.74 | 47 | 6114 | 0.0077 | 0.0994 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.18 | 21.74 | 11955 | 6114 | 1.9552 | 1.1718 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.15 | 21.74 | 773 | 6167 | 0.1253 | 0.5500 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.15 | 21.74 | 9347 | 6167 | 1.5155 | 1.1047 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.15 | 21.74 | 38 | 6167 | 0.0062 | 0.0709 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.15 | 21.74 | 12193 | 6167 | 1.9769 | 1.1745 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.12 | 21.74 | 675 | 6211 | 0.1087 | 0.5236 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.12 | 21.74 | 9517 | 6211 | 1.5321 | 1.1074 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.12 | 21.74 | 76 | 6211 | 0.0122 | 0.1658 | MN20160310_N01 | K18 |